Cargando…
Overcoming Cytosolic Delivery Barriers of Proteins Using Denatured Protein-Conjugated Mesoporous Silica Nanoparticles
[Image: see text] Intracellular delivery of therapeutic proteins has increased advantages over current small-molecule drugs and gene therapies, especially in therapeutic efficacies for a broad spectrum of diseases. Hence, developing the protein therapeutics approach provides a needed alternative. He...
Autores principales: | Dembélé, Julien, Liao, Jou-Hsuan, Liu, Tsang-Pai, Chen, Yi-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896485/ https://www.ncbi.nlm.nih.gov/pubmed/36562665 http://dx.doi.org/10.1021/acsami.2c17544 |
Ejemplares similares
-
Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier
por: Chen, Yi-Ping, et al.
Publicado: (2022) -
Mesoporous Silica Nanoparticles for Protein Protection and Delivery
por: Xu, Chun, et al.
Publicado: (2019) -
Smart Mesoporous Silica Nanoparticles for Protein Delivery
por: Liu, Hai-Jun, et al.
Publicado: (2019) -
Designing
Mesoporous Silica Nanoparticles to Overcome
Biological Barriers by Incorporating Targeting and Endosomal Escape
por: Gisbert-Garzarán, Miguel, et al.
Publicado: (2021) -
ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood–brain barrier
por: Shen, Yang, et al.
Publicado: (2018)